Louise Frausto - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Louise Frausto

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Vascular Pharmacology|December 5, 2025

Smooth muscle cell phenotypic modulation during atherosclerosisLouise Frausto, Matthew L Scott, A Wayne Orr, et al.

Blood Advances|January 9, 2026

Neutrophil CD14 is a Driver and a Therapeutic Target for Deep Vein ThrombosisNilesh Pandey, Harpreet Kaur, Raktim Mitra, et al.

Experimental Neurology|February 6, 2025

Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney diseaseHarpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Vascular Pharmacology|December 5, 2025

Smooth muscle cell phenotypic modulation during atherosclerosisLouise Frausto, Matthew L Scott, A Wayne Orr, et al.

Blood Advances|January 9, 2026

Neutrophil CD14 is a Driver and a Therapeutic Target for Deep Vein ThrombosisNilesh Pandey, Harpreet Kaur, Raktim Mitra, et al.

Experimental Neurology|February 6, 2025

Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney diseaseHarpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, et al.

Pageof 1